ALIBHLINFTECUNSPADR (Germany) Performance
| TWYA Stock | EUR 8.90 0.50 5.95% |
On a scale of 0 to 100, ALIBHLINFTECUNSPADR holds a performance score of 8. The firm shows a Beta (market volatility) of -0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ALIBHLINFTECUNSPADR are expected to decrease at a much lower rate. During the bear market, ALIBHLINFTECUNSPADR is likely to outperform the market. Please check ALIBHLINFTECUNSPADR's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether ALIBHLINFTECUNSPADR's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ALIBHLINFTECUNSPADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ALIBHLINFTECUNSPADR reported solid returns over the last few months and may actually be approaching a breakup point. ...more
ALIBHLINFTECUNSPADR |
ALIBHLINFTECUNSPADR Relative Risk vs. Return Landscape
If you would invest 650.00 in ALIBHLINFTECUNSPADR on September 12, 2024 and sell it today you would earn a total of 240.00 from holding ALIBHLINFTECUNSPADR or generate 36.92% return on investment over 90 days. ALIBHLINFTECUNSPADR is generating 0.7044% of daily returns assuming 6.8218% volatility of returns over the 90 days investment horizon. Simply put, 60% of all stocks have less volatile historical return distribution than ALIBHLINFTECUNSPADR, and 86% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ALIBHLINFTECUNSPADR Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ALIBHLINFTECUNSPADR's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ALIBHLINFTECUNSPADR, and traders can use it to determine the average amount a ALIBHLINFTECUNSPADR's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1033
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TWYA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.82 actual daily | 60 60% of assets are less volatile |
Expected Return
| 0.7 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average ALIBHLINFTECUNSPADR is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ALIBHLINFTECUNSPADR by adding it to a well-diversified portfolio.
ALIBHLINFTECUNSPADR Fundamentals Growth
ALIBHLINFTECUNSPADR Stock prices reflect investors' perceptions of the future prospects and financial health of ALIBHLINFTECUNSPADR, and ALIBHLINFTECUNSPADR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ALIBHLINFTECUNSPADR Stock performance.
| Return On Equity | 0.0088 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.02) % | |||
| Shares Outstanding | 676.01 M | |||
| Revenue | 22.72 B | |||
| EBITDA | (505.28 M) | |||
| Cash And Equivalents | 11.64 B | |||
| Cash Per Share | 17.30 X | |||
| Total Debt | 37.74 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 22.12 X | |||
| Cash Flow From Operations | 1.01 B | |||
| Earnings Per Share | 0.02 X | |||
About ALIBHLINFTECUNSPADR Performance
By analyzing ALIBHLINFTECUNSPADR's fundamental ratios, stakeholders can gain valuable insights into ALIBHLINFTECUNSPADR's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ALIBHLINFTECUNSPADR has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ALIBHLINFTECUNSPADR has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, medical and healthcare services, and digital infrastructure businesses in the Peoples Republic of China. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. ALIB HL operates under Pharmaceutical Retailers classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1033 people.Things to note about ALIBHLINFTECUNSPADR performance evaluation
Checking the ongoing alerts about ALIBHLINFTECUNSPADR for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ALIBHLINFTECUNSPADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ALIBHLINFTECUNSPADR is way too risky over 90 days horizon | |
| ALIBHLINFTECUNSPADR appears to be risky and price may revert if volatility continues | |
| ALIBHLINFTECUNSPADR has high likelihood to experience some financial distress in the next 2 years |
- Analyzing ALIBHLINFTECUNSPADR's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ALIBHLINFTECUNSPADR's stock is overvalued or undervalued compared to its peers.
- Examining ALIBHLINFTECUNSPADR's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ALIBHLINFTECUNSPADR's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ALIBHLINFTECUNSPADR's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ALIBHLINFTECUNSPADR's stock. These opinions can provide insight into ALIBHLINFTECUNSPADR's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ALIBHLINFTECUNSPADR Stock analysis
When running ALIBHLINFTECUNSPADR's price analysis, check to measure ALIBHLINFTECUNSPADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALIBHLINFTECUNSPADR is operating at the current time. Most of ALIBHLINFTECUNSPADR's value examination focuses on studying past and present price action to predict the probability of ALIBHLINFTECUNSPADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALIBHLINFTECUNSPADR's price. Additionally, you may evaluate how the addition of ALIBHLINFTECUNSPADR to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |